NATIONAL HEALTHCARE CORP - Common Stock (NHC) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
NHC on NYSE
Shares outstanding
15,520,216
Price per share
$137.09
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
9,505,209
Total reported value
$1,155,414,502
% of total 13F portfolios
0%
Share change
+479,320
Value change
+$59,981,857
Number of holders
203
Price from insider filings
$137.09
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of NATIONAL HEALTHCARE CORP - Common Stock (NHC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 12% $218,759,921 1,800,345 BlackRock, Inc. 30 Sep 2025
VANGUARD GROUP INC 9.2% $131,808,294 1,420,348 The Vanguard Group 31 Mar 2025

As of 30 Sep 2025, 203 institutional investors reported holding 9,505,209 shares of NATIONAL HEALTHCARE CORP - Common Stock (NHC). This represents 61% of the company’s total 15,520,216 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of NATIONAL HEALTHCARE CORP - Common Stock (NHC) together control 53% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 12% 1,882,905 -1.2% 0% $228,791,822
VANGUARD GROUP INC 9.2% 1,422,197 -1.3% 0% $172,811,157
DIMENSIONAL FUND ADVISORS LP 6.2% 965,565 -0.44% 0.03% $117,326,825
Morgan Stanley Institutional Investment Advisors LLC 4.8% 749,221 -0.39% 11% $91,037,844
STATE STREET CORP 3.2% 490,632 -0.41% 0% $59,928,371
M Holdings Securities, Inc. 3% 463,194 12% $56,283,000
RENAISSANCE TECHNOLOGIES LLC 2.4% 373,867 -3.5% 0.06% $45,428,579
GEODE CAPITAL MANAGEMENT, LLC 2% 316,079 +1.7% 0% $38,412,199
FIRST TRUST ADVISORS LP 1.3% 207,483 +556% 0.02% $25,211,259
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.2% 189,000 +3.5% 0% $22,965,390
ALPS ADVISORS INC 1.1% 176,002 +20% 0.12% $21,386,003
NORTHERN TRUST CORP 0.9% 140,334 +1.1% 0% $17,051,985
SYSTEMATIC FINANCIAL MANAGEMENT LP 0.77% 119,905 -0.13% 0.35% $14,569,842
Bank of New York Mellon Corp 0.77% 119,447 -1.6% 0% $14,513,996
MORGAN STANLEY 0.63% 98,129 -2.9% 0% $11,923,778
Invesco Ltd. 0.45% 70,448 -14% 0% $8,560,137
PRINCIPAL FINANCIAL GROUP INC 0.42% 65,012 +0.43% 0% $7,899,609
Manatuck Hill Partners, LLC 0.39% 60,400 0% 2.5% $7,339,204
GOLDMAN SACHS GROUP INC 0.39% 59,761 +25% 0% $7,261,504
JPMORGAN CHASE & CO 0.36% 55,210 +7.2% 0% $6,708,568
Pacer Advisors, Inc. 0.33% 51,204 -13% 0.02% $6,221,798
Hood River Capital Management LLC 0.31% 48,419 +4.8% 0.07% $5,883,393
PUBLIC SECTOR PENSION INVESTMENT BOARD 0.31% 48,382 +15% 0.02% $5,878,897
Allspring Global Investments Holdings, LLC 0.31% 48,296 +56% 0.01% $6,019,613
Nuveen, LLC 0.29% 45,128 0% 0% $5,483,504

Institutional Holders of NATIONAL HEALTHCARE CORP - Common Stock (NHC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 20,035 $2,741,948 +$407,775 $137.09 7
2025 Q3 9,505,209 $1,155,414,502 +$59,981,857 $121.51 203
2025 Q2 9,014,817 $965,006,048 -$2,384,983 $107.01 191
2025 Q1 9,066,636 $841,710,496 -$11,771,084 $92.80 180
2024 Q4 9,179,016 $987,555,102 -$13,776,461 $107.56 183
2024 Q3 9,256,377 $1,164,189,492 +$109,716,156 $125.77 195
2024 Q2 8,465,537 $917,958,315 +$14,615,209 $108.40 175
2024 Q1 8,325,881 $787,160,112 -$27,180,401 $94.51 167
2023 Q4 9,927 $917,454 +$409,677 $92.42 2
2023 Q3 7,360,641 $471,147,520 -$557,886 $63.98 130
2023 Q2 7,373,271 $455,942,774 +$11,806,723 $61.82 132
2023 Q1 7,141,064 $414,881,574 +$1,080,495 $58.07 134
2022 Q4 7,165,524 $426,559,937 +$12,333,992 $59.50 118
2022 Q3 6,887,931 $436,499,892 -$8,113,325 $63.34 118
2022 Q2 7,056,170 $493,410,425 +$9,639,598 $69.90 116
2022 Q1 7,009,045 $492,033,845 +$11,070,604 $70.23 116
2021 Q4 6,888,115 $468,011,833 -$7,166,195 $67.94 121
2021 Q3 6,930,869 $485,003,904 -$140,187 $69.98 122
2021 Q2 6,945,819 $485,526,994 -$5,404,199 $69.90 129
2021 Q1 7,055,658 $549,451,633 -$7,326,790 $77.91 124
2020 Q4 6,889,077 $457,656,524 +$5,025,439 $66.41 120
2020 Q3 7,023,870 $437,576,536 -$8,692,979 $62.31 118
2020 Q2 6,966,184 $441,972,644 -$21,219,213 $63.44 127
2020 Q1 7,469,082 $535,999,537 +$37,358,650 $71.73 137
2019 Q4 6,920,200 $597,442,510 +$24,215,229 $86.43 141
2019 Q3 6,701,878 $548,169,214 +$40,962,766 $81.85 132
2019 Q2 6,192,673 $502,063,106 -$8,767,019 $81.15 124
2019 Q1 6,379,872 $484,023,333 +$13,616,635 $75.88 121
2018 Q4 6,178,861 $484,823,336 +$13,050,277 $78.45 124
2018 Q3 5,998,879 $452,091,245 +$13,579,252 $75.37 117
2018 Q2 5,815,043 $409,307,460 +$7,057,533 $70.38 113
2018 Q1 5,738,431 $342,173,756 +$925,749 $59.63 116
2017 Q4 5,574,170 $339,869,261 -$1,449,404 $60.94 114
2017 Q3 5,663,493 $354,386,234 -$1,246,380 $62.57 110
2017 Q2 5,675,211 $398,054,344 +$7,498,364 $70.14 109
2017 Q1 5,562,786 $396,615,431 +$51,204,480 $71.30 103
2016 Q4 5,562,023 $421,582,620 +$24,012,827 $75.79 101
2016 Q3 5,252,888 $346,476,609 +$3,478,029 $65.99 107
2016 Q2 5,259,340 $340,498,570 +$5,051,972 $64.74 105
2016 Q1 5,140,062 $320,206,000 -$6,059,941 $62.30 105
2015 Q4 5,192,952 $320,430,453 +$8,416,649 $61.70 92
2015 Q3 5,044,208 $307,135,658 -$6,713,670 $60.89 88
2015 Q2 5,005,012 $325,264,423 +$10,217,822 $64.99 88
2015 Q1 4,980,426 $317,297,450 -$2,114,978 $63.71 86
2014 Q4 5,019,455 $315,443,140 -$1,231,092 $62.84 79
2014 Q3 5,042,597 $279,911,289 +$6,394,243 $55.51 86
2014 Q2 4,927,009 $277,319,595 +$1,610,146 $56.29 88
2014 Q1 4,897,476 $273,098,781 +$1,688,541 $55.77 80